Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report
2019 · Journal of Thoracic Oncology · 284 citations
https://doi.org/10.1016/j.jtho.2019.07.025
L
L. Paz-Ares
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
913
Citations
13
h-index
16
i10-index
L. Paz-Ares is an academic researcher from Hospital Universitario 12 De Octubre. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 13, co-authored 95 publications.
Papers by this author
worksSafety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy
2025 · ESMO Open · 8 citations
https://doi.org/10.1016/j.esmoop.2025.104538
Updated results of M7824 (MSB0011359C): A bifunctional fusion protein targeting TGF-β and PD-L1, in second-line (2L) NSCLC
2018 · Annals of Oncology · 7 citations
https://doi.org/10.1093/annonc/mdy292.085
Prevalence of programmed death ligand-1 (PD-L1) by demographic, disease and sample characteristics in unresectable, stage III NSCLC (PACIFIC)
2019 · Annals of Oncology · 2 citations
https://doi.org/10.1093/annonc/mdz067.002
Clinical Utility of Combined Plasma and Tissue NGS in Patients With Newly Diagnosed Advanced Non-Small Cell Lung Cancer
2023 · The Journal of Liquid Biopsy · 0 citations
https://doi.org/10.1016/j.jlb.2023.100016
2798eTiP A phase Ib/II study assessing [177Lu]Lu-DOTA-TATE plus standard of care as a first-line treatment for patients with extensive-stage small cell lung cancer
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.08.3409
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat